Literature DB >> 20518029

Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations.

Roger A Moore1, Andrew Timmes, Phillip A Wilmarth, Suzette A Priola.   

Abstract

Transmissible spongiform encephalopathies (TSEs) or prion diseases are characterized by the accumulation of an aggregated isoform of the prion protein (PrP). This pathological isoform, termed PrP(Sc), appears to be the primary component of the TSE infectious agent or prion. However, it is not clear to what extent other protein cofactors may be involved in TSE pathogenesis or whether there are PrP(Sc)-associated proteins which help to determine TSE strain-specific disease phenotypes. We enriched PrP(Sc) from the brains of mice infected with either 22L or Chandler TSE strains and examined the protein content of these samples using nanospray LC-MS/MS. These samples were compared with "mock" PrP(Sc) preparations from uninfected brains. PrP was the major component of the infected samples and ferritin was the most abundant impurity. Mock enrichments contained no detectable PrP but did contain a significant amount of ferritin. Of the total proteins identified, 32% were found in both mock and infected samples. The similarities between PrP(Sc) samples from 22L and Chandler TSE strains suggest that the non-PrP(Sc) protein components found in standard enrichment protocols are not strain specific.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518029      PMCID: PMC3742083          DOI: 10.1002/pmic.201000104

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  58 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Computational prediction of proteotypic peptides for quantitative proteomics.

Authors:  Parag Mallick; Markus Schirle; Sharon S Chen; Mark R Flory; Hookeun Lee; Daniel Martin; Jeffrey Ranish; Brian Raught; Robert Schmitt; Thilo Werner; Bernhard Kuster; Ruedi Aebersold
Journal:  Nat Biotechnol       Date:  2006-12-31       Impact factor: 54.908

3.  Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations.

Authors:  A Akowitz; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  Microb Pathog       Date:  1990-07       Impact factor: 3.738

4.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Towards purification of the scrapie agent.

Authors:  H Diringer; H Hilmert; D Simon; E Werner; B Ehlers
Journal:  Eur J Biochem       Date:  1983-08-15

6.  Insight into early events in the aggregation of the prion protein on lipid membranes.

Authors:  Narinder Sanghera; Marcus J Swann; Gerry Ronan; Teresa J T Pinheiro
Journal:  Biochim Biophys Acta       Date:  2009-08-21

7.  Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents.

Authors:  R J Kascsak; R Rubenstein; P A Merz; R I Carp; H M Wisniewski; H Diringer
Journal:  J Gen Virol       Date:  1985-08       Impact factor: 3.891

8.  Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.

Authors:  Leila H Choe; Alison Green; Richard S G Knight; Edward J Thompson; Kelvin H Lee
Journal:  Electrophoresis       Date:  2002-07       Impact factor: 3.535

9.  Gene expression alterations in brains of mice infected with three strains of scrapie.

Authors:  Pamela J Skinner; Hayet Abbassi; Bruce Chesebro; Richard E Race; Cavan Reilly; Ashley T Haase
Journal:  BMC Genomics       Date:  2006-05-16       Impact factor: 3.969

10.  Recombinant prion protein induces a new transmissible prion disease in wild-type animals.

Authors:  Natallia Makarava; Gabor G Kovacs; Olga Bocharova; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  Acta Neuropathol       Date:  2010-01-06       Impact factor: 17.088

View more
  21 in total

1.  Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.

Authors:  Monique Provansal; Stéphane Roche; Manuela Pastore; Danielle Casanova; Maxime Belondrade; Sandrine Alais; Pascal Leblanc; Otto Windl; Sylvain Lehmann
Journal:  Prion       Date:  2010-10-27       Impact factor: 3.931

Review 2.  Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).

Authors:  Andrew C Gill; Sonya Agarwal; Teresa J T Pinheiro; James F Graham
Journal:  Prion       Date:  2010-10-20       Impact factor: 3.931

3.  Cellular prion protein is present in mitochondria of healthy mice.

Authors:  Robert Faris; Roger A Moore; Anne Ward; Brent Race; David W Dorward; Jason R Hollister; Elizabeth R Fischer; Suzette A Priola
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

4.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

5.  Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Authors:  Roger A Moore; Andrew G Timmes; Phillip A Wilmarth; David Safronetz; Suzette A Priola
Journal:  Proteomics       Date:  2011-09-07       Impact factor: 3.984

6.  Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.

Authors:  Alexandra R Chesney; Clarissa J Booth; Christopher B Lietz; Lingjun Li; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2016-06-20       Impact factor: 9.028

7.  Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Authors:  Ajay Singh; Liuting Qing; Qingzhong Kong; Neena Singh
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

8.  Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra.

Authors:  Gerald S Baron; Andrew G Hughson; Gregory J Raymond; Danielle K Offerdahl; Kelly A Barton; Lynne D Raymond; David W Dorward; Byron Caughey
Journal:  Biochemistry       Date:  2011-05-03       Impact factor: 3.162

9.  Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death.

Authors:  Piyali Mukherjee; Tyson A Woods; Roger A Moore; Karin E Peterson
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

Review 10.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Matthew K McElwee; Katharine Horback; Amber Beserra
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.